Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Paniagua
Miguel A
MA
Hirsch
Irl B
IB
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D016729:Leuprolide / Q000009:adverse effects*; D008297:Male; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide; D016729:Leuprolide